BSG and melanoma: In our studies, using a large series of 196 cutaneous melanomas including primary and metastatic melanomas, we showed that high CD147 expression, assessed by immunohistochemistry, was significantly associated with the metastatic potential and with a reduced overall survival in primary melanoma patients.